These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16279289)

  • 1. The effects of an open design on trial participant recruitment, compliance and retention--a randomized controlled trial comparison with a blinded, placebo-controlled design.
    Avenell A; Grant AM; McGee M; McPherson G; Campbell MK; McGee MA;
    Clin Trials; 2004; 1(6):490-8. PubMed ID: 16279289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women.
    Prince RL; Devine A; Dhaliwal SS; Dick IM
    Arch Intern Med; 2006 Apr; 166(8):869-75. PubMed ID: 16636212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
    Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
    Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.
    van Bodegraven AA; Bravenboer N; Witte BI; Dijkstra G; van der Woude CJ; Stokkers PC; Russel MG; Oldenburg B; Pierik M; Roos JC; van Hogezand RA; Dik VK; Oostlander AE; Netelenbos JC; van de Langerijt L; Hommes DW; Lips P;
    Gut; 2014 Sep; 63(9):1424-30. PubMed ID: 24146170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study.
    Brazier M; Grados F; Kamel S; Mathieu M; Morel A; Maamer M; Sebert JL; Fardellone P
    Clin Ther; 2005 Dec; 27(12):1885-93. PubMed ID: 16507374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low acceptance of treatment in the elderly for the secondary prevention of osteoporotic fracture in the acute rehabilitation setting.
    Berry SD; Misra D; Hannan MT; Kiel DP
    Aging Clin Exp Res; 2010 Jun; 22(3):231-7. PubMed ID: 20634646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.
    Tang BM; Eslick GD; Nowson C; Smith C; Bensoussan A
    Lancet; 2007 Aug; 370(9588):657-66. PubMed ID: 17720017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.
    Grant AM; Avenell A; Campbell MK; McDonald AM; MacLennan GS; McPherson GC; Anderson FH; Cooper C; Francis RM; Donaldson C; Gillespie WJ; Robinson CM; Torgerson DJ; Wallace WA;
    Lancet; 2005 May 7-13; 365(9471):1621-8. PubMed ID: 15885294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trials: who fails run-in?
    Rees JR; Mott LA; Barry EL; Baron JA; Figueiredo JC; Robertson DJ; Bresalier RS; Peacock JL
    Trials; 2016 Jul; 17():374. PubMed ID: 27474021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial.
    Matsumoto T; Miki T; Hagino H; Sugimoto T; Okamoto S; Hirota T; Tanigawara Y; Hayashi Y; Fukunaga M; Shiraki M; Nakamura T
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5031-6. PubMed ID: 15972580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.
    Tee SI; Yosipovitch G; Chan YC; Chua SH; Koh ET; Chan YH; Tan SS; Tsou IY; Tan SH
    Arch Dermatol; 2012 Mar; 148(3):307-14. PubMed ID: 22105813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.
    Di Daniele N; Carbonelli MG; Candeloro N; Iacopino L; De Lorenzo A; Andreoli A
    Pharmacol Res; 2004 Dec; 50(6):637-41. PubMed ID: 15501704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial.
    Meyer HE; Smedshaug GB; Kvaavik E; Falch JA; Tverdal A; Pedersen JI
    J Bone Miner Res; 2002 Apr; 17(4):709-15. PubMed ID: 11918228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment and retention of urban schoolchildren into a randomized double-blind vitamin D supplementation trial.
    Sacheck JM; Van Rompay MI; Olson EM; Chomitz VR; Goodman E; Gordon CM; Eliasziw M; Holick MF; Economos CD
    Clin Trials; 2015 Feb; 12(1):45-53. PubMed ID: 25349179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
    Bonnick S; De Villiers T; Odio A; Palacios S; Chapurlat R; DaSilva C; Scott BB; Le Bailly De Tilleghem C; Leung AT; Gurner D
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4727-35. PubMed ID: 24064689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial.
    Greenspan SL; Perera S; Ferchak MA; Nace DA; Resnick NM
    JAMA Intern Med; 2015 Jun; 175(6):913-21. PubMed ID: 25867538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The American Orthopaedic Association's "own the bone" initiative to prevent secondary fractures.
    Tosi LL; Gliklich R; Kannan K; Koval KJ
    J Bone Joint Surg Am; 2008 Jan; 90(1):163-73. PubMed ID: 18171971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.